scholarly journals Gram-negative blood-stream infections in patiens with hepatobliopancreatic tumors

HPB ◽  
2018 ◽  
Vol 20 ◽  
pp. S757
Author(s):  
E. Laviano ◽  
T. González-Nicolas ◽  
M. Sanchez ◽  
S. Genzor ◽  
T. Gimenez ◽  
...  
Keyword(s):  
Blood Stream ◽  
Blood Stream Infections ◽  
Gram Negative

Prevalence and antibiogram of non-fermenting Gram-negative bacilli in blood stream infections: Study in a tertiary care centre, Western Uttar Pradesh, India

2021 ◽  
pp. 004947552097929
Author(s):  
Tarana Sarwat ◽  
Mariyah Yousuf ◽  
Ambreen S Khan ◽  
Dalip K Kakru ◽  
Renu Dutta
Keyword(s):  
Burkholderia Cepacia ◽  
Tertiary Care ◽  
Uttar Pradesh ◽  
Blood Stream ◽  
Care Centre ◽  
Tertiary Care Centre ◽  
Acinetobacter Baumanii ◽  
Blood Stream Infections ◽  
Antibiotic Susceptibility Pattern ◽  
Gram Negative

Non-fermenting Gram-negative bacilli (NFGNB) are emerging as important cause of blood stream infections. We aimed to determine the prevalence and antibiotic susceptibility pattern of NFGNB isolated from blood of patients with sepsis. We found, in 176 patients, the most common to be Pseudomonas aeruginosa (74) and Acinetobacter baumanii complex (39) followed by Stenotrophomonas maltophilia (16), Sphingomonas paucimobilis (6), Burkholderia cepacia (5) and Ochrobactrum anthropic (1). Generally, organisms showed a good sensitivity towards colistin, carbapenems and fluoroquinolones, whereas cephalosporins were ineffective.

scholarly journals Susceptibility Pattern of Pathogens Causing Blood Stream Infections in a Tertiary Care Hospital: A Two-year Retrospective Study from Southern Nigeria

2021 ◽  
pp. 53-60
Author(s):  
Bassey Ewa Ekeng ◽  
Ubleni Ettah Emanghe ◽  
Bernard Ekpan Monjol ◽  
Anthony Achizie Iwuafor ◽  
Ernest Afu Ochang ◽  
...  
Keyword(s):  
Staphylococcus Aureus ◽  
Blood Culture ◽  
Blood Stream ◽  
Multidrug Resistant ◽  
Diffusion Method ◽  
Disc Diffusion ◽  
Blood Stream Infections ◽  
Gram Negative ◽  
Antimicrobial Sensitivity ◽  
Culture Positive

Aim: Bloodstream infections are a major cause of morbidity and mortality worldwide. The prevalence of causative microorganisms varies from one geographical region to another. This study was aimed at determining the etiological agents prevalent in our environment and their susceptibility profile. Study design: This is a retrospective study carried out at the University of Calabar Teaching Hospital, Calabar, Nigeria. Methodology: Blood culture results of patients documented over a two-year period were retrieved and analyzed. Blood culture positive isolates were detected using conventional method and Oxoid signal blood culture systems. Antimicrobial sensitivity tests were carried out by Kirby-Bauer disc diffusion method. Methicillin resistance in Staphylococcus aureus and coagulase negative Staphylococcus species (CoNS) was detected by disk diffusion method using 30 µg cefoxitin disk. ESBL production was detected by phenotypic confirmatory disc diffusion test (PCDDT) and the double disc synergy test (DDST). Results: A total of 413 blood culture antimicrobial susceptibility test results were analyzed, of which 116 (28.09%) were identified as culture positive. Sixty-nine (59%) of the positive isolates were from female patients. Out of 116 positive cultures, 58.62% (68/116) were Gram positive organisms, 40.52% (47/116) were Gram negative organisms, non albicans Candida accounted for 0.86% (1/116).  Staphylococcus aureus (n=41, 35.3%) was the predominant isolate and showed high sensitivity to levofloxacin (100%), Linezolid (100%) and Amikacin (100%). Twelve isolates of S. aureus were methicillin resistant, while 1 isolate was inducible clindamycin resistant. Of the 116 isolates identified in this study, forty-three (43) were multidrug resistant with highest number of multidrug resistant isolates from Staphylococcus aureus (n=20). 21.28% (n=10) of the Gram-negative isolates were positive for extended spectrum beta lactamases. Conclusion: A high rate of antimicrobial resistance is observed among microorganisms causing blood stream infections. This emphasizes the need for antimicrobial sensitivity testing in the management of blood stream infections.

scholarly journals Impact of Accelerate Pheno System on Time to Antimicrobial Stewardship Intervention in Patients with Gram-Negative Blood Stream Infections

2017 ◽  
Vol 4 (suppl_1) ◽  
pp. S627-S628
Author(s):  
Gerald Elliott ◽  
Michael Postelnick ◽  
David Martin ◽  
Viktorija Barr ◽  
Michael Malczynski ◽  
...  
Keyword(s):  
Antimicrobial Stewardship ◽  
Blood Stream ◽  
Blood Stream Infections ◽  
Gram Negative

Defining Central Line-Associated Blood Stream Infections Following Hematopoietic Cell Transplantation in Acute Myeloid Leukemia and Myelodysplastic Syndrome.

Blood ◽  
2012 ◽  
Vol 120 (21) ◽  
pp. 3042-3042 ◽  
Author(s):  
Joshua Lukenbill ◽  
Lisa Rybicki ◽  
Mikkael A. Sekeres ◽  
Megan DiGiorgio ◽  
Thomas Fraser ◽  
...  
Keyword(s):  
Acute Myeloid Leukemia ◽  
Myeloid Leukemia ◽  
Hematopoietic Cell Transplantation ◽  
Blood Stream ◽  
Central Line ◽  
Streptococcus Viridans ◽  
Blood Stream Infections ◽  
Gram Negative ◽  
Definition Of ◽  
Acute Myeloid

Abstract Abstract 3042 Central line-associated blood stream infection (CLABSI) surveillance is increasingly utilized as an objective measure of quality of care provided by individual hospitals. CLABSI is defined by the National Healthcare Safety Network (NHSN) as a primary bloodstream infection (BSI) in a patient with a central line within the 48-hour period before the development of the BSI (NHSN CLABSI). This traditional definition of CLABSI includes pathogens better described as hospital-acquired blood stream infections (HABSI), such as enteric gram-negative bacilli (GNB) and streptococcus viridans - pathogens inherently more common in patients undergoing hematopoietic cell transplantation (HCT) due to the resultant neutropenia and disruption of mucosal barriers, and unlikely to be line-related. To avoid this misclassification, we have developed a modified CLABSI definition (MCLABSI) which excludes HABSI (DiGiorgio, Infect Control Hosp Epidemiol. 33: 865–8, 2012). MCLABSI includes all of the pathogens under the NHSN definition of CLABSI except Viridans group streptococci species in patients with mucositis, and Enterococcus, Enterobacteriaceae, or Candida species in patients with neutropenia or graft-vs-host disease of the gut. We compared the incidence of CLABSI and its impact on survival using both definitions in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) patients undergoing SCT. AML and MDS patients undergoing HCT between August 2009 and December 2011 were identified from the Cleveland Clinic Unified Transplant Database, and NHSN CLABSI and MCLABSI rates were obtained from the infection control database. CLABSI incidence was estimated using Kaplan-Meier method, and risk factors for mortality were identified using stepwise Cox proportional hazards analyses. Of the 73 patients identified (median age 52, range 16–70), 48 were male, 44 had AML, and 29 MDS. Patients received a median of 2 prior chemotherapy regimens (range 0–6), 3 had prior radiation, and 6 had prior transplant. 54 underwent myeloablative and 19 reduced-intensity preparative regimens; stem cell source included bone marrow (BM, n=34), peripheral stem cells (PSC, n=24), and cord blood cells (CBC, n=15). The median CD34+ count was 2.42 × 106/kg and median time to neutrophil recovery (absolute neutrophil count > 500/μL) was 14 days (range 6–24) with BM/PSC and 28 days (range 19–77) with CBC. Most (88%) had mucositis, including 17 (28%) with grade 3 or 4. Twenty-three (31.5%) developed NHSN CLABSI, compared to 8 (11.0%) who developed MCLABSI following HCT, of whom 16 (69.6%) and 7 (87.5%) died, respectively. The majority (16/23) of NHSN CLABSI occurred within 14 days (median 9 days, range 2–211 days) of HCT (Figure), varying from a median of 5 days (range 2–12 days) for CBC and 78 days for BM/PSC (range 7–211 days, p<.001). Pathogens in NHSN CLABSI included 11 enteric Gram-negative bacilli, 7 Streptococcus viridans group, 6 enterococcus (3 vancomycin resistant), 5 Staphylococcus (3 methicillin resistant), 2 fungal species, 2 Gram-positive bacilli, 1 Pseudomonas, 1 other Streptococcus species, and 1 Stenotrophomonas. MCLABSI occurred a median of 12 days (range 5–176 days) from HCT (Figure), 7 days for CBC (range 5–12 days) compared to 77 days (range 13–176 days) for BM/PSC (p<.001). Pathogens isolated in MCLABSI included 5 Staphylococcal species (3 MRSE), 2 Streptococcus viridans group, 2 GPB, 1 VRE, and 1 Pseudomonas. 4 NHSN CLABSI and 2 MCLABSI were polymicrobial, and 4 patients had recurrent CLABSI (all of whom died, including 3 MCLABSI). When NHSN CLABSI was analyzed as a time-varying covariate in univariable analysis, it was associated with an increased risk of mortality (HR 3.72, 95% CI 1.88 – 7.36, p<.001), as was MCLABSI (HR 2.96, CI 1.27–6.89, p=.012). CLABSI remained a significant risk factor for mortality in multivariable analysis, by both the NHSN (HR 7.14, CI 3.31 – 15.31, p<.001) and MCLABSI (HR 6.44, CI 2.28–18.18, p<.001) definitions. CLABSI is a common complication in AML and MDS patients undergoing SCT, and is associated with decreased survival. CLABSI is identified less commonly with the exclusion of HABSI in the modified definition, which more precisely identifies patients with BSI related to their central lines. The distinction between these definitions is important to guide preventative infectious control measures, particularly given CLABSI's role as a quality measure influencing reimbursement. Disclosures: Hill: Teva Pharmaceuticals: Honoraria, Speakers Bureau.

scholarly journals Spectrum of non-fermenting gram negative bacilli isolated from patients with blood stream infections in a tertiary care hospital in North India

2019 ◽  
Vol 7 (5) ◽  
pp. 1762
Author(s):  
Asifa Nazir ◽  
Bushra Yousuf Peerzada ◽  
Ifshana Sana
Keyword(s):  
Blood Culture ◽  
Antibiotic Susceptibility ◽  
Tertiary Care ◽  
Blood Stream ◽  
Control Measures ◽  
Care Hospital ◽  
Susceptibility Pattern ◽  
Intrinsic Resistance ◽  
Blood Stream Infections ◽  
Gram Negative

Background: Non-fermenting Gram-negative bacilli (NFGNB) are emerging as important causes of blood stream infections (BSI) and they are a major cause of morbidity and mortality worldwide. High intrinsic resistance of NFGNB to antimicrobial compounds makes the treatment of BSIs caused by them difficult and expensive. The aim of this study was to assess frequency and antibiotic susceptibility pattern of non-fermenting gram-negative rods isolated from blood culture of patients.Methods: A total of 3016 blood samples were received in the Department of Microbiology during the study period. All samples were processed according to standard microbiological procedures. Blood culture was done by automated blood culture system, (BacT/Alert) and identification and antibiotic susceptibility of non-fermenting gram negative bacilli was done by VITEK2 Compact System.Results: A total of 120 NFGNB were identified out of which the most common non-fermenters isolated were Acinetobacter sp. (95) followed by Pseudomonas aeruginosa (11), Burkholderia cepacia (09) Sternotrophomonas maltophilia (03) and Sphingomonas sp. (02). Most of the non -fermenters were multi drug resistant showing a high level of antibiotic resistance to most of the first- and second-line drugs. The most effective drugs were colistin and tigecycline.Conclusions: This study underlines the need to identify NFGNB in tertiary care hospitals and to monitor their susceptibility pattern to guide the clinician for better care and management of patients. Improved antibiotic stewardship and strict infection control measures especially hand washing need to be implemented to prevent emergence and spread of multidrug resistant NFGNB in health care settings.

scholarly journals Omitting Fluoroquinolones Antibiotic Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplantation Does Not Increase Gram-Negative Bacteremia Rate or Transplant-Related Mortality

Blood ◽  
2020 ◽  
Vol 136 (Supplement 1) ◽  
pp. 34-35
Author(s):  
Israel Henig ◽  
Oryan Henig ◽  
Haggai Bar-Yoseph ◽  
Hanin Daoud ◽  
Dana Yehudai-Ofir ◽  
...  
Keyword(s):  
Stem Cell ◽  
Hematopoietic Stem Cell Transplantation ◽  
Blood Stream ◽  
Intestinal Microbiome ◽  
Gram Negative Bacteria ◽  
Blood Stream Infections ◽  
Hematopoietic Stem ◽  
Gram Negative ◽  
Microbiome Diversity ◽  
Related Mortality

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is widely utilized as a curative treatment for malignant and non-malignant hematological conditions. Fluoroquinolone prophylaxis (FQ-P) is demonstrated to reduce the rate of blood stream infections (BSI) caused by gram-negative bacteria (GNB) during allo-HSCT and increases overall survival (OS), making this approach the standard of care. The available data show that during the transplantation period, the intestinal microbiome diversity profoundly decreases, which is associated with a significant increase in transplant-related mortality (TRM), acute graft-versus-host disease (aGVHD) related mortality and decrease in OS. FQ-P is reported to be a dominant factor in the perturbation of the gut microbiota, leading some centers to omit or modify transplant antibiotic prophylaxis regimens. The aim of the present study has been to evaluate the effects of FQ-P omission on the prevalence of gram-negative bacteria blood stream infections (GNB-BSI), GNB susceptibility to antibiotic treatment, mortality of patients with sepsis and overall TRM. This retrospective single-center study included all consecutive patients, admitted to the Rambam Department of Hematology for allo-HSCT between 01.01.2017 and 31.12.2019. The fact that at our center, FQ-P in allo-HSCT recipients was discontinued on 01.12.2018 allowed comparison of the outcomes in patients treated with and without such prophylaxis. GNB-BSI events registered within 30 days of admission were analyzed. The proportion of first-time GNB-BSI, the antibiotic susceptibility profile, day 30 and day 90 mortality among patients with GNB-BSI were compared. The assessment also included day 30 and day 90 overall TRM, mortality related to sepsis and aGVHD. During the evaluated period, 189 patients underwent allo-HSCT and were included in the analysis. FQ-P was administered to 125 patients and omitted in 64 individuals. GNB-BSI events occurred in 23 (18.4%) patients receiving FQ-P and in 17 (26.6%) patients who did not receive it (p=0.19). GNB susceptibility to FQ, piperacillin/tazobactam and meropenem increased from 38.1% to 58.8%, from 60% to 70.6% and from 85.7% to 94.1%, respectively, after FQ-P had been stopped (p=non-significant, NS). 30-day and 90-day mortality among patients with GNB-BSI did not increase in the post-FQ-P period (Table 1). Day 30 and day 90 overall TRM rates were 10.6% and 18.9%, respectively, with FQ-P versus 13.5% and 21.9%, respectively, without FQ-P (p=NS). Before FQ-P was stopped, sepsis was the cause of death in 56% of events and aGVHD in 16% and after FQ-P was stopped, the corresponding values were 46% and 23%, respectively (p=NS). FQ-P omission has not significantly increased the rate of GNB-BSI or affected the profile of GNB susceptibility to antibiotic treatment in patients undergoing allo-HSCT. Moreover, it has not significantly changed day 30 and day 90 mortality either among patients with GNB-BSI or in the entire study population. FQ-P omission in allo-HSCT recipients appears to be safe and its implementation could contribute to the preservation of intestinal microbiome diversity, potentially leading to improved post-transplant outcome. The findings of this study need to be further evaluated in large randomized trials. Disclosures No relevant conflicts of interest to declare.

Incidence and Outcome of Bacterial Blood Stream Infections in Allotransplanted Patients: Rethinking the Role of Fluoroquinolone Prophylaxis

Blood ◽  
2016 ◽  
Vol 128 (22) ◽  
pp. 2223-2223
Author(s):  
Benedetta Rambaldi ◽  
Michele Malagola ◽  
Giuseppe Ravizzola ◽  
Giorgio Giannetta ◽  
Nicola Polverelli ◽  
...  
Keyword(s):  
Stem Cell ◽  
Peripheral Blood ◽  
Antimicrobial Prophylaxis ◽  
Blood Stream ◽  
Gram Positive ◽  
Blood Stream Infections ◽  
Hematopoietic Stem ◽  
Gram Negative ◽  
Positive Group ◽  
E Coli

Abstract Introduction. Blood stream infections (BSIs) represent a common event during allogeneic hematopoietic stem cell transplantation (allo-SCT) and are associated with high rate of mortality. Prophylaxis with fluoroquinolones is commonly adopted to prevent severe infection during the neutropenic phase. The emerging bacterial strains resistant to these antimicrobial agents could lead to change this type of approach. Patients and methods. We retrospectively analyzed positive blood cultures (BCs) from patients allotransplanted from January 2010 to December 2015 within our transplant program. Antimicrobial prophylaxis was conducted with a quinolone during the neutropenic period, acyclovir and fluconazole starting from the day prior to reinfusion until the withdrawn of immunosuppressive therapy and sulfametoxazole/trimethoprim starting from the hematological recovery. GVHD prophylaxis consisted on cyclosporine and methotrexate in all cases, with the addition of ATG in patients transplanted from matched unrelated donor (MUD) or with cord-blood (CB) units. Post-transplant cyclophosphamide was used in the setting of haploidentical donors. At fever onset, BCs were collected from peripheral blood (PB-BCs) and central venous catheter (CVC-BCs). A CVC related infection was defined when a positive CVC-BC proceeded by 2 hours the positivity of PB-BCs. CVC contamination was defined by the presence of positive CVC-BCs and negative PB-BCs. Empirical broad-spectrum antimicrobial therapy was usually conduct with a third or fourth generation cephalosporin with the addiction of a glycopeptide agent, if mucositis occurred. Results. One hundred-sixty-two patients underwent allo-SCT of whom 88 (54%) had acute leukemia (AL); 70 (43%) were transplanted in first CR or up-front; 71 (44%) received a myeloablative conditioning (MAC). The stem cell source was bone marrow (BM) in 33 (20%), peripheral blood stem cells (PBSC) in 122 (75%) and CB in 7 (5%) cases. Donors were matched related donor (MRD) in 58 (36%), MUD in 86 (53%) and alternative (haploidentical or CB) in 18 (11%) cases. The median time to positive BCs since allo-SCT was 13 days (range -4 - +1482). Eighty patients (49%) had a positive BCs, for a total of 119 samples. No difference in the clinical characteristics of patients with or without BSI was detected (Table 1). The median follow up was 399 days (range 21-2039) for the BSI positive group and 437 (range 12-2157) for the BSI negative (p=0.52). In 43 out of 80 patients with BSI (53%) we observed a correlation between the BCs and an organ involvement (mainly the lung in 34% of the cases). Seventy-seven (65%) and 42 (35%) out of 119 BCs were sustained by a Gram positive and a Gram negative agent, respectively. The distribution and the antimicrobial sensitivity of the different species is reported in Table 2. Briefly, S. epidermidis and E. coli were the most frequently isolated Gram positive and Gram negative bacteria, respectively (35% and 20%). 67% of E. coli were ESBL positive and 92% were resistant to fluoroquinolones. Moreover 40% and 90% of P. aeruginosa were resistant to carbapenems and to fluoroquinolones, respectively. Sixty (50%) and 59 (50%) out of 119 BCs were CVC-BCs and PB-BCs, respectively. Regarding positive CVC-BCs, 28 (24%) were CVC related BSIs; CVC contamination was observed in 21 cases (18%). The most common isolate from CVC-BCs was S. epidermidis, with 25 cases (21%). Forty -seven out of 80 patients (59%) in the BSI positive group and 35 out of 82 (43%) in the BSI negative group died (p=0.04). Overall, the infection-related mortality was 19% (15 cases). Species with the higher mortality rate were: P. aeruginosa (50%) and E. faecium (67%). Conclusions: Prophylaxis with fluoroquinolones predominantly selects Gram positive infections the majority of which were CVC related. Infections by Gram negative strains are frequently characterized by multi-antimicrobial agent resistance. These results urge to reconsider the antimicrobial prophylaxis strategy. Prospective surveillance of BSIs is a mainstay in the management of patients addressed to allo-SCT. Disclosures No relevant conflicts of interest to declare.

Sign in / Sign up

Export Citation Format

Share Document